Search results
Results from the WOW.Com Content Network
Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. [2] Atopic dermatitis is also often called simply eczema but the same term is also used to refer to dermatitis, the larger group of skin conditions. [2] [5] Atopic dermatitis results in itchy, red, swollen, and cracked skin. [2]
The term atopic dermatitis was coined in 1933 by Wise and Sulzberger. [95] Sulfur as a topical treatment for eczema was fashionable in the Victorian and Edwardian eras. [84] The word dermatitis is from the Greek δέρμα derma 'skin' and -ῖτις-itis 'inflammation' and eczema is from Greek: ἔκζεμα ekzema 'eruption'. [96]
Atopic dermatitis is a chronic dermatitis associated with a hereditary tendency to develop allergies to food and inhalant substances. [ 46 ] [ 47 ] [ 48 ] Atopic dermatitis (atopic eczema, disseminated neurodermatitis, flexural eczema, infantile eczema, prurigo diathsique)
Atopic dermatitis is a chronic dermatitis associated with a hereditary tendency to develop allergies to food and inhalant substances. Pages in category "Atopic dermatitis" The following 10 pages are in this category, out of 10 total.
The SCORAD ("SCORing Atopic Dermatitis") index is a clinical tool for assessing the extent of the disease, disease intensity, and subjective symptoms of atopic dermatitis. [1] It gives approximate weights of 60% to intensity and 20% each to extent and subjective symptoms.
In the developed world, about 20% of people are affected by allergic rhinitis, [15] about 6% of people have at least one food allergy, [3] [5] and about 20% have or have had atopic dermatitis at some point in time. [16] Depending on the country, about 1–18% of people have asthma. [17] [18] Anaphylaxis occurs in between 0.05–2% of people. [19]
Tralokinumab is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy. [5] [3]In the United States, tralokinumab is indicated for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Children affected by allergies in the developed world: [2] 1 in 13 have eczema; 1 in 8 have allergic rhinitis; 3-6% are affected by food allergy; Children in the United States under 18 years of age: [3]